Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
CAR-T Cell Therapy for Lymphoma
Recruiting1 awardPhase 1
Chapel Hill, North Carolina
This trial is testing a new way to fight cancer by combining two different types of cells. Antibodies are proteins that protect the body from disease, and T cells are special blood cells that can kill other cells, including cancer cells. The new treatment, ATLCAR.CD30.CCR4, is a combination of these two types of cells, and it is being tested to see if it is more effective than either one alone.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.